Japanese pharmaceutical firm Shionogi & Co said Friday it has applied for approval of its oral COVID-19 drug, after mid-phase clinical trials showed efficacy in reducing the coronavirus…
Japanese pharmaceutical firm Shionogi & Co said Friday it has applied for approval of its oral COVID-19 drug, after mid-phase clinical trials showed efficacy in reducing the coronavirus…